AU2001251242A1 - Methods and compositions for regulating memory consolidation - Google Patents
Methods and compositions for regulating memory consolidationInfo
- Publication number
- AU2001251242A1 AU2001251242A1 AU2001251242A AU5124201A AU2001251242A1 AU 2001251242 A1 AU2001251242 A1 AU 2001251242A1 AU 2001251242 A AU2001251242 A AU 2001251242A AU 5124201 A AU5124201 A AU 5124201A AU 2001251242 A1 AU2001251242 A1 AU 2001251242A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- memory consolidation
- regulating memory
- regulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pathology (AREA)
- Psychiatry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19361400P | 2000-03-31 | 2000-03-31 | |
US60/193,614 | 2000-03-31 | ||
PCT/US2001/010661 WO2001074298A2 (en) | 2000-03-31 | 2001-04-02 | Methods and compositions for regulating memory consolidation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001251242A1 true AU2001251242A1 (en) | 2001-10-15 |
Family
ID=22714335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001251242A Abandoned AU2001251242A1 (en) | 2000-03-31 | 2001-04-02 | Methods and compositions for regulating memory consolidation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1331930A2 (en) |
JP (1) | JP2004508288A (en) |
AU (1) | AU2001251242A1 (en) |
WO (1) | WO2001074298A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689557B1 (en) * | 1994-10-07 | 2004-02-10 | Cold Spring Harbor Laboratory | Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
WO2002052042A2 (en) * | 2000-12-22 | 2002-07-04 | Medical Research Council | Method for assaying compounds |
AU2003202489A1 (en) * | 2002-01-10 | 2003-07-30 | Takeda Chemical Industries, Ltd. | Screening method |
AUPS255202A0 (en) * | 2002-05-27 | 2002-06-13 | Monash University | Agents and methods for the treatment of disorders associated with motor neuron degeneration |
US20060040338A1 (en) * | 2004-08-18 | 2006-02-23 | Odyssey Thera, Inc. | Pharmacological profiling of drugs with cell-based assays |
US20060094059A1 (en) * | 2004-09-22 | 2006-05-04 | Odyssey Thera, Inc. | Methods for identifying new drug leads and new therapeutic uses for known drugs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7015190B1 (en) * | 1996-06-03 | 2006-03-21 | The Trustees Of Columbia University In The City Of New York | Method for enhancing long-term memory in a subject and uses thereof |
WO2001068137A2 (en) * | 2000-03-14 | 2001-09-20 | Brown University Research Foundation | Compositions for regulating memory consolidation |
-
2001
- 2001-04-02 JP JP2001572044A patent/JP2004508288A/en not_active Withdrawn
- 2001-04-02 EP EP01924598A patent/EP1331930A2/en not_active Withdrawn
- 2001-04-02 WO PCT/US2001/010661 patent/WO2001074298A2/en not_active Application Discontinuation
- 2001-04-02 AU AU2001251242A patent/AU2001251242A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001074298A3 (en) | 2003-05-22 |
JP2004508288A (en) | 2004-03-18 |
EP1331930A4 (en) | 2003-08-06 |
WO2001074298A2 (en) | 2001-10-11 |
EP1331930A2 (en) | 2003-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3946402A (en) | Methods and compositions for regulating memory consolidation | |
AU2001239947A1 (en) | Methods and compositions for regulating adipocytes | |
AU2001285409A1 (en) | Memory devices and methods for use therewith | |
AU2778801A (en) | Antisense compositions and methods | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2001258801A1 (en) | Gelling composition | |
AU2001219651A1 (en) | Mulch composition and method | |
AU2001293189A1 (en) | Compositions and methods for regulating apoptosis | |
AU2001286651A1 (en) | Microparticle composition and method | |
AU2001256347A1 (en) | Deodorant and/or antiperspirant compositions | |
AU2002213114A1 (en) | Compositions and methods for reducing gnrh-induced bone loss | |
AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
AU2001292864A1 (en) | Methods and compositions for modulating angiogenesis | |
AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
AU2002224525A1 (en) | Compositions for regulating desire for smoking | |
AU2001243635A1 (en) | Methods and compositions for regulating memory consolidation | |
AU2001275409A1 (en) | Methods and compositions for controlled polypeptide synthesis | |
AU2001233932A1 (en) | Method and composition | |
AU2001251242A1 (en) | Methods and compositions for regulating memory consolidation | |
AU2001267382A1 (en) | Antiperspirant and/or deodorant compositions | |
AU1615701A (en) | Compositions and methods for regulating tumor-associated antigen expression | |
AU2001261513A1 (en) | Composition and method for increasing testosterone levels | |
AU2002239775A1 (en) | Chemical-library composition and method | |
IL145289A0 (en) | Method and compositions for regulating memory consolidation | |
AU2002365136A1 (en) | Compositions and methods for controlled release |